Erratum: Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury (Inflammation DOI:10.1007/s10753-012-9571-1);Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury

Inflammation

Volumn 36, Issue 2, 2013, Pages 501-511

  Chi, Gefu ^a   Wei, Miaomiao ^b,c   Xie, Xianxing ^b   Soromou, L W ^b   Liu, Fang ^b   Zhao, Shuhua ^c  

^a INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^b JILIN UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

limonene; lipopolysaccharide (LPS); mitogen activated protein kinase (MAPK); nuclear factor B (NF B)

Indexed keywords

DEXAMETHASONE; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIMONENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; HISTOPATHOLOGY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS;

EID: 84879501903     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9623-1     Document Type: Erratum

References (43)

1. Repine, J.E. 1992. Scientific perspectives on adult respiratory distress syndrome. Lancet 339: 466e9.
2. Ware, L.B.; and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334e49.
3. Sato, K.; M.B. Kadiiska, A.J. Ghio, et al. 2002. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. The FASEB Journal 16: 1713-1720.
4. Matthay, M.A.; G.A. Zimmerman, C. Esmon, J. Bhattacharya, B. Coller, C.M. Doerschuk, J. Floros, and M.A. Gimbrone. 2003. Future research directions in acute lung injury. American Journal of Respiratory and Critical Care Medicine 167: 1027-1035.
5. Rubenfeld, G.D.; E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, et al. 2005. Incidence and outcomes of acute lung injury. The New England Journal of Medicine 353: 1685-1693.
6. Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
7. Chen, Z.; X. Zhang, X. Chu, X. Zhang, K. Song, Y. Jiang, L. Yu, and X. Deng. 2010. Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice. Inflammation 33: 306-314.
8. Yang, Ruhui, Lina Yang, Xiangchun Shen, Wenyuan Cheng, Bohua Zhao, Kazi Hamid Ali, Zhiyu Qian, and Hui Ji. 2012. Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 674: 391-396.
9. Di, R.; M.T. Huang, and C.T. Ho. 2011. Anti-inflammatory activities of mogrosides from Momordica grosvenori in murine macrophages and a murine ear edema model. Journal of Agricultural and Food Chemistry 59: 7474-7481.
10. Kim, E.K.; and E.J. Choi. 2010. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta 1802: 396-405.
11. Song, H.Y.; J.A. Lee, S.M. Ju, K.Y. Yoo, M.H. Won, H.J. Kwon, et al. 2008. Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochemical Pharmacology 75: 1348-1357.
12. 2, and proinflammatory cytokines in RAW 264.7 macrophages. Journal of Oleo Science 59: 415-421.
13. Chaudhary, S.C.; M.S. Siddiqui, M. Athar, Sarwar, and M. Alam. 2012. D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis. Human and Experimental Toxicology 31: 798-811.
14. Hirota, Ryoji, Ngatu Nlandu Roger, Hiroyuki Nakamura, Hee-sun Song, Masayoshi Sawamura, and Narufumi Suganuma. 2010. Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils. Journal of Food Science 75: 87-92.
15. Matthay, M.A.; G.A. Zimmerman, C. Esmon, J. Bhattacharya, B. Coller, C.M. Doerschuk, et al. 2003. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. American Journal of Respiratory and Critical Care Medicine 167: 1027-1035.
16. Rubenfeld, G.D. 2003. Epidemiology of acute lung injury. Critical Care Medicine 31: 276-284.
17. Knapp, S.; S. Florquin, D.T. Golenbock, and T. van der Poll. 2006. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. Journal of Immunology 176: 3189-3195.
18. Chen, H.; C. Bai, and X. Wang. 2010. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Review of Respiratory Medicine 4: 773-783.
19. Cepkova, M.; and M.A. Matthay. 2006. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. Journal of Intensive Care Medicine 21: 119-143.
20. Teder, P.; R.W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P.M. Henson, and P.W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158.
21. Abraham, E. 2003. Neutrophils and acute lung injury. Critical Care Medicine 31: 195-199.
22. Bachofen, M.; and E.R. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clinics in Chest 3: 35-56.
23. Klebanoff, S.J. 2005. Myeloperoxidase: friend and foe. Journal of Leukemia Biology 77: 598-625.
24. Zhang, X.M.; K.J. Song, H.Z. Xiong, H.Y. Li, X. Chu, and X.M. Deng. 2009. Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 9: 1525-1529.
25. Bhatia, M.; and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 202: 145-156.
26. Minamino, T.; and I. Komuro. 2006. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. The Journal of Clinical Investigation 116: 2316-2319.
27. Ganter, M.T.; J. Roux, B. Miyazawa, M. Howard, J.A. Frank, G. Su, et al. 2008. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. Circulation Research 102: 804-812.
28. Giebelen, I.A.; D.J. van Westerloo, G.J. LaRosa, et al. 2007. Local stimulation of a7 cholinergic receptors inhibits LPS-induced TNF-a release in the mouse lung. Shock 28: 700.
29. Marsh, C.B.; and M.D. Wewers. 1996. The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection. Clinics in Chest Medicine 17: 183-197.
30. Bouros, D.; M.G. Alexandrakis, K.M. Antoniou, et al. 2004. The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome. BMC Pulmonary Medicine 4: 6.
31. Goodman, R.B.; J. Pugin, J.S. Lee, and M.A. Matthay. 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine & Growth Factor Reviews 14: 523-535.
32. Li, Y.C.; C.H. Yeh, M.L. Yang, and Y.H. Kuan. 2012. Luteolin suppresses inflammatory mediator expression by blocking the Akt/NFκB pathway in acute lung injury induced by lipopolysaccharide in mice. Evidence-Based Complementary and Alternative Medicine 2012: 383608.
33. Sasaki, J.; S. Fujishima, H. Iwamura, K. Wakitani, S. Aiso, and N. Aikawa. 2003. Prior burn insult induces lethal acute lung injury in endotoxemic mice: effects of cytokine inhibition. American Journal of Physiology. Lung Cellular and Molecular Physiology 284: 270-278.
34. Moine, P.; R. McIntyre, M.D. Schwartz, et al. 2000. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85-91.
35. Baeuerle, P.A.; and D. Baltimore. 1996. NF-κB: ten years after. Cell 87: 13-20.
36. Gilmore, T.D. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25: 6680-6684.
37. Lee, J.C.; and P.R. Young. 1996. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. Journal of Leukocyte Biology 59: 152-157.
38. Jarrar, D.; J.F. Kuebler, L.W. Rue, S. Matalon, P. Wang, K.I. Bland, et al. 2002. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. American Journal of Physiology. Lung Cellular and Molecular Physiology 283: 799-805.
39. Candrian, S.S.; V.F.J. Quesniaux, F. Di Padova, I. Maillet, N. Nicolas, I. Couillin, R. Moser, F. Erard, B.B. Vargaftig, B. Ryffel, and B. Schnyder. 2005. Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. Journal of Immunology 175: 262-269.
40. Kim, H.J.; H.S. Lee, Y.H. Chong, and J.L. Kang. 2006. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264 7 macrophages. Toxicology 225: 36-47.
41. Pan, P.; J. Cardinal, R. Dhupar, M.R. Rosengart, M.T. Lotze, D.A. Geller, et al. 2009. Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality. Journal of Leukocyte Biology 86: 625-632.
42. Song, G.Y.; C.S. Chung, I.H. Chaudry, and A. Ayala. 2001. MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. American Journal of Physiology. Cell Physiology 281: 662-669.
43. Schuh, K.; and A. Pahl. 2009. Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury. Biochemical Pharmacology 77: 1827-1834.